Hancom MDS Inc (086960) — Capital Reinvestment Ratio
Hancom MDS Inc (086960) has a Capital Reinvestment Ratio of 0.27x as of March 2026, meaning it reinvests 0% of its operating cash flow (₩6.11 Billion) in capital expenditures (₩1.65 Billion). Check 086960 tangible net worth ratio to evaluate the tangible quality of the company's equity base.
Capital Reinvestment Ratio
Operating Cash Flow
Capital Expenditures
Data as of
Hancom MDS Inc Capital Reinvestment Ratio (2007–2025)
This chart tracks Hancom MDS Inc's Capital Reinvestment Ratio across 14 annual periods. For the full cash flow conversion analysis, see Hancom MDS Inc operating cash flow efficiency.
Annual Capital Reinvestment Ratio for Hancom MDS Inc (2007–2025)
Year-by-year Capital Reinvestment Ratio for Hancom MDS Inc from 2007 to 2025. See Hancom MDS Inc (086960) free cash flow to measure how efficiently the company converts operating cash flow to free cash.
| Year | Reinvestment Ratio | Operating CF (KRW) | Capital Expenditures | YoY Change |
|---|---|---|---|---|
| 2025 | 0.25x | ₩16.12 Billion | ₩4.04 Billion | ▼ -48.8% |
| 2024 | 0.49x | ₩2.90 Billion | ₩1.42 Billion | ▲ +1514.7% |
| 2023 | 0.03x | ₩26.32 Billion | ₩798.10 Million | ▼ -93.2% |
| 2021 | 0.45x | ₩2.83 Billion | ₩1.27 Billion | ▲ +22.0% |
| 2020 | 0.37x | ₩6.78 Billion | ₩2.48 Billion | ▼ -17.7% |
| 2019 | 0.44x | ₩4.95 Billion | ₩2.20 Billion | ▲ +146.7% |
| 2018 | 0.18x | ₩20.47 Billion | ₩3.69 Billion | ▼ -45.1% |
| 2017 | 0.33x | ₩3.57 Billion | ₩1.17 Billion | ▼ -54.3% |
| 2015 | 0.72x | ₩6.27 Billion | ₩4.50 Billion | ▲ +393.2% |
| 2014 | 0.15x | ₩12.73 Billion | ₩1.85 Billion | ▼ -45.1% |
| 2013 | 0.27x | ₩12.06 Billion | ₩3.20 Billion | ▼ -71.4% |
| 2012 | 0.93x | ₩6.63 Billion | ₩6.17 Billion | ▲ +563.2% |
| 2011 | 0.14x | ₩4.76 Billion | ₩667.39 Million | ▲ +4.5% |
| 2007 | 0.13x | ₩7.05 Billion | ₩946.15 Million | — |